Mona Shahbazi

Perceptions of sexuality in individuals with Amyotrophic Lateral Sclerosis (ALS) and their treating clinicians.

Gioia Ciani, Mona Shahbazi, Shara Holzberg, 2017, NeuroRehabilitation.

Pyrimethamine significantly lowers cerebrospinal fluid Cu/Zn superoxide dismutase in amyotrophic lateral sclerosis patients with SOD1 mutations

S. Ajroud‐Driss, P. Andersen, A. Ludolph, 2017, Annals of Neurology.

Differential gene expression in patients with amyotrophic lateral sclerosis

Mona Shahbazi, Stuart C Sealfon, S. Sealfon, 2011, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Pyrimethamine significantly lowers cerebrospinal fluid Cu/Zn superoxide dismutase in amyotrophic lateral sclerosis patients with SOD1 mutations

S. Ajroud‐Driss, P. Andersen, A. Ludolph, 2017, Annals of neurology.

A specific biomarker for amyotrophic lateral sclerosis: Quantitative susceptibility mapping.

Yi Wang, A. Tsiouris, B. Shen, 2021, Clinical imaging.

Quantitative susceptibility mapping of the motor cortex in amyotrophic lateral sclerosis and primary lateral sclerosis.

Tian Liu, Yi Wang, Ajay Gupta, 2015, AJR. American journal of roentgenology.

Quantitative Susceptibility Mapping (QSM) as a biomarker for C9orf72 Familial ALS (P6.027)

Yi Wang, Tian Liu, A. Tsiouris, 2015 .

Assessment of corticospinal tract dysfunction and disease severity in amyotrophic lateral sclerosis

Edward P. Furlani, Rahul Remanan, Viktor Sukhotskiy, 2016, 1609.08980.

REM behavior disorder associated with familial amyotrophic lateral sclerosis

A. Krieger, D. Lange, M. Ebben, 2012, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Pyrimethamine Significantly Lowers CSF/SOD1 in ALS Patients With SOD1 Mutations

P. Andersen, A. Ludolph, S. Marklund, 2017 .